Scienture Holdings (SCNX) Non Operating Investment Income (2019)
Scienture Holdings' (SCNX) quarterly Non Operating Investment Income came in at -$162178.0 in Q3 2019, down 175.58% quarter-over-quarter from -$58850.0 in Q2 2019.
Powered by 
Analysis
Scienture Holdings (SCNX) Non Operating Investment Income (2019) Analysis & Trends
Scienture Holdings has disclosed Non Operating Investment Income across 1 years of filings, most recently posting -$162178.0 for Q3 2019.
- In Q3 2019, Non Operating Investment Income changed N/A year-over-year to -$162178.0; the TTM figure through Dec 2019 stood at -$250000.0 (changed N/A YoY), while the FY2019 annual figure was -$250000.0, changed N/A from the prior year.
- Non Operating Investment Income came in at -$162178.0 for Q3 2019 at Scienture Holdings, down from -$58850.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of -$28972.0 in Q1 2019 to a low of -$162178.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | -162,178.00 |
| Jun 30, 2019 | -58,850.00 |
| Mar 31, 2019 | -28,972.00 |